Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 4:03 pm Purchase |
2025-03-10 | 13G | Outset Medical, Inc. OM |
PFM Health Sciences, LP | 1,666,667 9.400% |
1,666,667 (New Position) |
Filing History |
| 2025-02-21 4:02 pm Purchase |
2025-02-13 | 13G | PMV Pharmaceuticals, Inc. PMVP |
PFM Health Sciences, LP | 2,598,827 5.000% |
2,598,827 (New Position) |
Filing History |
| 2025-02-14 4:07 pm Sale |
2024-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 2,905,465 6.500% |
-493,282 (-14.51%) |
Filing History |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 0 0.000% |
-2,742,936 (Position Closed) |
Filing History |
| 2024-11-14 4:04 pm Sale |
2024-09-30 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 2,742,936 6.200% |
-519,564 (-15.93%) |
Filing History |
| 2024-11-14 4:04 pm Sale |
2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 3,398,747 7.800% |
-69,430 (-2.00%) |
Filing History |
| 2024-11-14 4:03 pm Sale |
2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU |
PFM Health Sciences, LP | 4,306,671 4.800% |
-2,174,093 (-33.55%) |
Filing History |
| 2024-10-22 4:02 pm Unchanged |
2024-10-15 | 13G | Bright Minds Biosciences Inc. DRUG |
PFM Health Sciences, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:06 pm Purchase |
2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
PFM Health Sciences, LP | 656,548 0.500% |
471,384 (+254.58%) |
Filing History |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | bluebird bio, Inc. BLUE |
PFM Health Sciences, LP | 102,133 1.900% |
-198,960 (-66.08%) |
Filing History |
| 2024-02-14 4:06 pm Purchase |
2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
PFM Health Sciences, LP | 6,480,764 7.300% |
2,020,981 (+45.32%) |
Filing History |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 3,262,500 7.400% |
-581,832 (-15.13%) |
Filing History |
| 2024-02-14 4:06 pm Purchase |
2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 3,468,177 9.600% |
1,646,357 (+90.37%) |
Filing History |
| 2023-04-21 4:08 pm Purchase |
2023-04-11 | 13G | bluebird bio, Inc. BLUE |
PFM Health Sciences, LP | 301,092 5.700% |
301,092 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | IO Biotech, Inc. IOBT |
PFM Health Sciences, LP | 507,640 1.800% |
-1,002,496 (-66.38%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Generation Bio Co. GBIO |
PFM Health Sciences, LP | 2,903,192 4.900% |
-110,520 (-3.67%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE |
PFM Health Sciences, LP | 345,926 0.700% |
-3,626,942 (-91.29%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Outset Medical, Inc. OM |
PFM Health Sciences, LP | 0 0.000% |
-196,017 (Position Closed) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
PFM Health Sciences, LP | 29,061,060 3.000% |
-25,597,620 (-46.83%) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
PFM Health Sciences, LP | 185,164 5.900% |
19,862 (+12.02%) |
Filing History |